Literature DB >> 10350497

Water-in-sorbitan monostearate organogels (water-in-oil gels).

S Murdan1, B van den Bergh, G Gregoriadis, A T Florence.   

Abstract

Novel multicomponent organogels containing an aqueous phase are described, and some properties which influence their potential as delivery devices for hydrophilic drugs and vaccines are discussed. The gel is produced by preparing a hot water-in-oil (w/o) emulsion using sorbitan monostearate, a nonionic surfactant which is also the organogelator, as the principal emulsifying agent. On cooling at room temperature, the w/o emulsion sets to an opaque, semisolid, thermoreversible organic gel. Cooling the emulsion results in a reduced solubility of the sorbitan monostearate in the oil, with a corresponding decrease in solvent-surfactant affinities, causing surfactant self-assembly into aggregates. The microstructure of the w/o gel is seen by light microscopy to consist of a network of tubules and fibrils (containing the aqueous phase) dispersed in the organic medium. X-ray diffraction and freeze-fracture studies suggest that the tubular aggregates in the w/o gel are made up of surfactant molecules arranged in inverted bilayers and that the aqueous phase is accommodated within these inverted bilayers, bound by the polar headgroups of the surfactant molecules. The presence of water in the tubular skeleton of the organic gels results in the establishment of percolating electroconductive aqueous channels in the organogel. Increasing the water content of a w/o gel causes the surfactant tubules to swell with a corresponding increase in conductivity until the tubules are saturated. Further increase in the water content results in the excess water accumulating in droplets within the organic medium and a decrease in conductivity as the gel integrity is compromised. The w/o gels (containing a model antigen, radiolabeled bovine serum albumin, in the aqueous phase) have demonstrated depot properties after intramuscular administration to mice, entrapped antigen being released over a period of days.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350497     DOI: 10.1021/js980343j

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride.

Authors:  Sambhaji Pisal; Vijay Shelke; Kakasaheb Mahadik; Shivajirao Kadam
Journal:  AAPS PharmSciTech       Date:  2004-09-13       Impact factor: 3.246

2.  In situ-forming pharmaceutical organogels based on the self-assembly of L-alanine derivatives.

Authors:  Anne-Claude Couffin-Hoarau; Aude Motulsky; Pascal Delmas; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

3.  In vitro evaluation of proniosomes as a drug carrier for flurbiprofen.

Authors:  Mahmoud Mokhtar Ahmed Ibrahim; Omaima A Sammour; Mohamed A Hammad; Nagia A Megrab
Journal:  AAPS PharmSciTech       Date:  2008-06-28       Impact factor: 3.246

4.  Rheology and Tribology of Ethylcellulose-Based Oleogels and W/O Emulsions as Fat Substitutes: Role of Glycerol Monostearate.

Authors:  Ruoning Zhang; Yanhui Zhang; Jingjing Yu; Yanxiang Gao; Like Mao
Journal:  Foods       Date:  2022-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.